Patient age, sex, number of liver metastases, chemotherapy, timing of metastasis, tumor differentiation, MMR protein status, and serum CRP levels did not differ significantly by ETBF-DNA group (Table 1). This evidence concerns the gene MRC1 and neoplasm.